Vyne Therapeutics (NASDAQ:VYNE) stock is taking off on Wednesday as investors take an interest in the pharmaceutical company.

Source: yurakrasil/Shutterstock.com

Here’s everything investors need to know about VYNE stock and the company today.

• Vyne Therapeutics is a pharmaceutical company with a focus on developing topical treatments for acne.
• It currently has two products on the market.
• The first of these is ZILXI, which treats inflammatory lesions of rosacea in adults.
• Second is AMZEEQ, which treats “severe acne vulgaris in adults and pediatric patients 9 years of age and older.”
• Recent news from the company includes it announcing a major deal with a pharmacy benefit manager (PBM).
• The deal covers both ZILXI and AMZEEQ.

• Vyne Therapeutics notes that the PBM in the deal is one of the largest in the U.S. and that it manages millions of lives.
• Another reason investors might be taking interest in VYNE stock could be a recent YouTube video from Market Gains.
• The video goes over details of institutional investors that have bought stakes in the company recently.
• It currently has about 84,000 views and was uploaded on Saturday.
• With the increased interest in VYNE stock comes heavy trading of its shares.
• As of this writing, more than 56 million shares of the stock have changed hands.
• That’s a massive spike compared to the company’s daily average trading volume of 1.67 million shares.

VYNE stock was up 27.1% as of Monday morning.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article.